Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Young Ae Kim 7 Articles
Cancer News Coverage in Korean Newspapers: An Analytic Study in Terms of Cancer Awareness
Hye Sook Min, E Hwa Yun, Jinsil Park, Young Ae Kim
J Prev Med Public Health. 2020;53(2):126-134.   Published online February 13, 2020
DOI: https://doi.org/10.3961/jpmph.19.256
  • 3,637 View
  • 112 Download
  • 3 Crossref
AbstractAbstract AbstractSummary PDF
Objectives
Cancer diagnoses have a tremendous impact on individuals and communities, drawing intense public concern. The objective of the current research was to examine news coverage and content related to cancer-related issues in Korean newspapers.
Methods
Primarily using the database system of the Korea Press Foundation, we conducted a content analysis of 2806 articles from 9 Korean daily newspapers during a recent 3-year period from 2015 to 2017. Thematic categories, the types of articles, attitudes and tone, and the number of sources in each article were coded and classified.
Results
Many news articles dealt with a diverse range of themes related to cancer, including general healthcare information, the latest research and development, specific medical institutions and personnel, and technology and products, which jointly accounted for 74.8% of all articles. Those thematic categories differed markedly in terms of article type, tone, and the number of cited sources. News articles provided extensive information about healthcare resources, and many articles seemed to contain advertising content. However, the content related to complex social issues such as National Health Insurance did not include enough information for the reader to contextualize the issues properly or present the issues systematically.
Conclusions
It can be assumed that the media exert differential influence on individuals through news coverage. Within the present reporting framework, the availability and usefulness of information are likely to depend solely on individuals’ capabilities, such as financial and health literacy; this dependency has a negative impact on knowledge gaps and health inequities.
Summary
Korean summary
암과 관련된 최근 3년간(2015년~2017년) 9개 전국 종합일간지의 보도를 한국언론재단 자료를 기반으로 조사 분석한 결과, 2,806개의 뉴스기사에서 일반적 암 정보, 최신 연구개발 소식, 병원 및 의료진 정보, 의료기기 및 신기술 정보 등 다양한 주제를 다루었다. 주제와 함께 기사 형태, 어조, 정보원을 분석한 결과, 암 관련 뉴스기사는 병원 및 의료진, 의료기기 및 신기술 정보를 중심으로 광고성 내용을 함께 포함하는 경우가 많았고, 건강보험 등 복합 분석이 필요한 주제에서는 심층적이고 포괄적인 분석이 드물고 내용을 단순화하는 경향이 있었다. 이러한 뉴스기사의 보도 틀은 암과 관련된 건강 및 질병 문제의 해결을 개인화하고 결과적으로 정보 격차 및 건강 불평등에 부정적 영향을 미칠 수 있다.

Citations

Citations to this article as recorded by  
  • Global research trends on precision oncology: A systematic review, bibliometrics, and visualized study
    Baoyue Zhang, Bo Ao, Xinyue Lu, Shuang Yang, Pengfei Bao, Hongyun Wang, Ruifeng Li, Youliang Huang
    Medicine.2022; 101(43): e31380.     CrossRef
  • Calls to Action (Mobilizing Information) on Cancer in Online News: Content Analysis
    Thomas Hongjie Zhang, Jen Sern Tham
    Journal of Medical Internet Research.2021; 23(6): e26019.     CrossRef
  • Newspaper representations of hand, foot and mouth disease (HFMD) and cancer in a Malaysian newspaper
    Su-Hie Ting, Nursilah Kapiten
    Communication and Medicine.2021; 17(1): 32.     CrossRef
The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
Dongwoo Kim, Seok-Jun Yoon, Young-Hoon Gong, Young Ae Kim, Hye-Young Seo, Jihyun Yoon, A-Rim Kim
J Prev Med Public Health. 2015;48(4):180-187.   Published online July 20, 2015
DOI: https://doi.org/10.3961/jpmph.15.022
  • 9,332 View
  • 113 Download
  • 12 Crossref
AbstractAbstract PDF
Objectives
Metabolic syndrome is an important etiologic factor in the development of certain types of cancers. The economic cost of the treatment of cancer has been steadily increasing. We therefore estimated the economic burden of cancers attributable to metabolic syndrome in Korea.
Methods
We reviewed metabolic syndrome-related cancers and relative risk and then calculated population attributable fractions. We analyzed insurance claims data for metabolic syndrome-related cancers in 2012 in order to estimate the direct costs associated with these cancers, including hospitalization, outpatient visits, transportation costs, and caregivers’ costs as well as indirect costs such as loss of productivity due to cancer treatment and premature death.
Results
In 2012, 18 070 patients in Korea had cancers attributable to metabolic syndrome. The economic burden was USD 199.8 million and the direct and indirect costs were USD 124.5 million and USD 75.3 million, respectively.
Conclusions
We estimated the economic burden of cancers attributable to metabolic syndrome in Korea and the efforts are necessary to reduce this burden.
Summary

Citations

Citations to this article as recorded by  
  • Predicting Habitual Use of Wearable Health Devices Among Middle-aged Individuals With Metabolic Syndrome Risk Factors in South Korea: Cross-sectional Study
    Jaeyoung Ha, Jungmi Park, Sangyi Lee, Jeong Lee, Jin-Young Choi, Junhyoung Kim, Sung-il Cho, Gyeong-Suk Jeon
    JMIR Formative Research.2023; 7: e42087.     CrossRef
  • Tools to assess employment readiness for colorectal cancer survivors: A scoping review
    Mingshuang Ding, Elise Gane, Harry Wiffen, Venerina Johnston
    Cancer Medicine.2023; 12(17): 18327.     CrossRef
  • Prevalence of Metabolic Syndrome and Its Association with Sociodemographic Characteristics in Participants of a Public Chronic Disease Control Program in Medellin, Colombia, in 2018


    Luis Felipe Higuita-Gutiérrez, Wilson de Jesús Martínez Quiroz, Jaiberth Antonio Cardona-Arias
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 1161.     CrossRef
  • Cross-sectional study of the prevalence and risk factors of metabolic syndrome in a rural population of the Qianjiang area
    Bing Ling, Li Zhao, Jixiu Yi
    Medicine.2020; 99(35): e21574.     CrossRef
  • The Economic Burden of Cancers Attributable to Infection in the Republic of Korea: A Prevalence-Based Study
    Thi Xuan Trinh Nguyen, Minji Han, Moran Ki, Young Ae Kim, Jin-Kyoung Oh
    International Journal of Environmental Research and Public Health.2020; 17(20): 7592.     CrossRef
  • The economic burden of cancers attributable to smoking in Korea, 2014
    Thi Nguyen, Minji Han, Jin-Kyoung Oh
    Tobacco Induced Diseases.2019;[Epub]     CrossRef
  • The economic burden of cancer attributable to obesity in Korea: A population‐based cohort study
    Joo Eun Lee, Chung Mo Nam, Sang Gyu Lee, Sohee Park, Tae Hyun Kim, Eun‐Cheol Park
    European Journal of Cancer Care.2019;[Epub]     CrossRef
  • The Prevalence of Metabolic Syndrome and Its Related Risk Complications among Koreans
    Seung-Hoo Lee, Shuting Tao, Hak-Seon Kim
    Nutrients.2019; 11(8): 1755.     CrossRef
  • Association between Low-Intensity Smoking and Metabolic Syndrome in Korean Men
    Minji Park, Seran Min, Yu Jin Cho, Sunwoo Kim, Hyuktae Kwon, Hee-Kyung Joh, Bumjo Oh, Seung-Won Oh, Ho Chun Choi, Cheol Min Lee
    Journal of the Korean Society for Research on Nicotine and Tobacco.2019; 10(2): 89.     CrossRef
  • Toenail Chromium Concentration and Metabolic Syndrome among Korean Adults
    Jakyung Son, J. Steven Morris, Kyong Park
    International Journal of Environmental Research and Public Health.2018; 15(4): 682.     CrossRef
  • The prevalence trend of metabolic syndrome and its components and risk factors in Korean adults: results from the Korean National Health and Nutrition Examination Survey 2008–2013
    Binh Thang Tran, Bo Yoon Jeong, Jin-Kyoung Oh
    BMC Public Health.2017;[Epub]     CrossRef
  • The Korean Gastric Cancer Cohort Study: Study Protocol and Brief Results of a Large-Scale Prospective Cohort Study
    Bang Wool Eom, Young-Woo Kim, Byung-Ho Nam, Keun Won Ryu, Hyun-Yong Jeong, Young-Kyu Park, Young-Joon Lee, Han-Kwang Yang, Wansik Yu, Jeong-Hwan Yook, Geun Am Song, Sei-Jin Youn, Heung Up Kim, Sung-Hoon Noh, Sung Bae Park, Doo-Hyun Yang, Sung Kim
    Journal of Gastric Cancer.2016; 16(3): 182.     CrossRef
Economic Burden of Colorectal Cancer in Korea
Ju-Young Byun, Seok-Jun Yoon, In-Hwan Oh, Young Ae Kim, Hye-Young Seo, Yo-Han Lee
J Prev Med Public Health. 2014;47(2):84-93.   Published online March 31, 2014
DOI: https://doi.org/10.3961/jpmph.2014.47.2.84
  • 14,587 View
  • 148 Download
  • 18 Crossref
AbstractAbstract PDF
Objectives

The incidence and survival rate of colorectal cancer in Korea are increasing because of improved screening, treatment technologies, and lifestyle changes. In this aging population, increases in economic cost result. This study was conducted to estimate the economic burden of colorectal cancer utilizing claims data from the Health Insurance Review and Assessment Service.

Methods

Economic burdens of colorectal cancer were estimated using prevalence data and patients were defined as those who received ambulatory treatment from medical institutions or who had been hospitalized due to colorectal cancer under the International Classification of Disease 10th revision codes from C18-C21. The economic burdens of colorectal cancer were calculated as direct costs and indirect costs.

Results

The prevalence rate (per 100 000 people) of those who were treated for colorectal cancer during 2010 was 165.48. The economic burdens of colorectal cancer in 2010 were 3 trillion and 100 billion Korean won (KRW), respectively. Direct costs included 1 trillion and 960 billion KRW (62.85%), respectively and indirect costs were 1 trillion and 160 billion (37.15%), respectively.

Conclusions

Colorectal cancer has a large economic burden. Efforts should be made to reduce the economic burden of the disease through primary and secondary prevention.

Summary

Citations

Citations to this article as recorded by  
  • Estimating the economic burden of colorectal cancer in China, 2019–2030: A population‐level prevalence‐based analysis
    Hong Wang, Yan‐Jie Li, Lin Lei, Cheng‐Cheng Liu, Wan‐Qing Chen, Min Dai, Xin Wang, Jie‐Bin Lew, Ju‐Fang Shi, Ni Li, Jie He
    Cancer Medicine.2024;[Epub]     CrossRef
  • Relationship Between Aspirin Use and Site-Specific Colorectal Cancer Risk Among Individuals With Metabolic Comorbidity
    Seokyung An, Madhawa Gunathilake, Jeonghee Lee, Minji Kim, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Cost of illness for colorectal cancer in Japan - a time trend and future projections (1996–2035) based on governmental statistics
    Kunichika Matsumoto, Yosuke Hatakeyama, Kanako Seto, Ryo Onishi, Koki Hirata, Yinghui Wu, Tomonori Hasegawa
    BMC Health Services Research.2023;[Epub]     CrossRef
  • Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
    Bander Balkhi, Ahmed Alghamdi, Saeed Alqahtani, Marwan Al Najjar, Abdullah Al Harbi, Thamer Bin Traiki
    Saudi Pharmaceutical Journal.2023; 31(11): 101822.     CrossRef
  • A performance measurement framework for socially sustainable and resilient supply chains using environmental goods valuation methods
    Aref A. Hervani, Santosh Nandi, Marilyn M. Helms, Joseph Sarkis
    Sustainable Production and Consumption.2022; 30: 31.     CrossRef
  • Direct medical costs of young-onset colorectal cancer: a worldwide systematic review
    Ria Garg, Vicki Cheng, Ursula Ellis, Vanay Verma, Helen McTaggart-Cowan, Stuart Peacock, Jonathan M. Loree, Mohsen Sadatsafavi, Mary A. De Vera
    BMC Health Services Research.2022;[Epub]     CrossRef
  • Economic Burden of Colorectal Cancer: A Case of Fars, Iran
    Abdosaleh Jafari, Peyman Mehdi Alamdarloo, Mehdi Dehghani, Peivand Bastani, Ramin Ravangard
    Cancer Control.2021; 28: 107327482110099.     CrossRef
  • Quality of life and costs of patients prior to colorectal surgery
    M. Pattamatta, B. J. J. Smeets, S. M. A. A. Evers, E. G. Peters, M. D. P. Luyer, M. Hiligsmann
    Expert Review of Pharmacoeconomics & Outcomes Research.2020; 20(2): 193.     CrossRef
  • Socioeconomic Burden of Cancer in Korea from 2011 to 2015
    Young Ae Kim, Ye-Rin Lee, Jeongjoo Park, In-Hwan Oh, Hoseob Kim, Seok-Jun Yoon, Keeho Park
    Cancer Research and Treatment.2020; 52(3): 896.     CrossRef
  • The Direct and Indirect Costs of Colorectal Cancer in Vietnam: An Economic Analysis from a Social Perspective
    Binh Thang Tran, Kui Son Choi, Thanh Xuan Nguyen, Dae Kyung Sohn, Sun-Young Kim, Jae Kyung Suh, Van Sang Phan, Huu Tri Pham, Minh Hanh Nguyen, Thanh Binh Nguyen, Huu Khoi Hoang, Thi Thanh Binh Nguyen, Minh Tu Nguyen, Jin-Kyoung Oh
    International Journal of Environmental Research and Public Health.2020; 18(1): 12.     CrossRef
  • Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study
    In Cheol Hwang, Jooyoung Chang, Sang Min Park, Suminori Akiba
    PLOS ONE.2017; 12(12): e0189114.     CrossRef
  • Analysis of Productivity Costs in Cancer: A Systematic Review
    Jordi Gol-Montserrat, María Luisa M. del Burgo, Luis Quecedo, Juan E. del Llano
    Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish.2017; 4(1): grhta.5000262.     CrossRef
  • The Economic Burden of Hepatitis A, B, and C in South Korea
    Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh
    Japanese Journal of Infectious Diseases.2016; 69(1): 18.     CrossRef
  • Dehydroglyasperin D Inhibits the Proliferation of HT-29 Human Colorectal Cancer Cells Through Direct Interaction With Phosphatidylinositol 3-kinase
    Sung Keun Jung, Chul-Ho Jeong
    Journal of Cancer Prevention.2016; 21(1): 26.     CrossRef
  • The Economic Burden of Cancer in Korea in 2009
    So Young Kim, Jong-Hyock Park, Kyoung Hee Kang, Inuk Hwang, Hyung Kook Yang, Young-Joo Won, Hong-Gwan Seo, Dukhyoung Lee, Seok-Jun Yoon
    Asian Pacific Journal of Cancer Prevention.2015; 16(3): 1295.     CrossRef
  • The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
    Dongwoo Kim, Seok-Jun Yoon, Young-Hoon Gong, Young Ae Kim, Hye-Young Seo, Jihyun Yoon, A-Rim Kim
    Journal of Preventive Medicine and Public Health.2015; 48(4): 180.     CrossRef
  • Trends in Colorectal Cancer Incidence in Daejeon and Chungcheongnam-do, South Korea (2000-2012)
    Soon-Young Kim, In-Sun Kweon, Jung-A Kim, Tae-Yong Lee, Hae-Sung Nam
    Journal of agricultural medicine and community health.2015; 40(3): 115.     CrossRef
  • FOXM1-mediated downregulation of uPA and MMP9 by 3,3′-diindolylmethane inhibits migration and invasion of human colorectal cancer cells
    HUA JIN, XIU JUAN LI, MAN HEE PARK, SOO MI KIM
    Oncology Reports.2015; 33(6): 3171.     CrossRef
The Economic Burden of Epilepsy in Korea, 2010
Jaehun Jung, Hye-Young Seo, Young Ae Kim, In-Hwan Oh, Yo Han Lee, Seok-Jun Yoon
J Prev Med Public Health. 2013;46(6):293-299.   Published online November 28, 2013
DOI: https://doi.org/10.3961/jpmph.2013.46.6.293
  • 9,883 View
  • 126 Download
  • 11 Crossref
AbstractAbstract PDF
Objectives

The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010.

Methods

This study used a prevalence based approach to calculate the cost of epilepsy. Claims data from the Korean national health insurance and data from the Korea health panel, the Korea National Statistical Office's records of causes of death, and labor statistics were used to estimate the cost of epilepsy. Patients were defined as those who were hospitalized or visited an outpatient clinic during 2010 with a diagnosis of epilepsy (International Classification of Diseases 10th revision codes G40-G41). Total costs of epilepsy included direct medical costs, direct non-medical cost and indirect costs.

Results

The annual prevalence of treated epilepsy was 228 per 100 000 population, and higher in men. The age-specific prevalence was highest for teenagers. The total economic burden of epilepsy was 536 billion Korean won (KW). Indirect cost (304 billion KW) was 1.3 times greater than direct cost (232 billion KW). By gender, the male (347 billion KW) were more burdened than the female (189 billion KW). The estimated cost in young age younger than 20 years old was 24.5% of the total burden of epilepsy.

Conclusions

A significant portion of the economic burden of epilepsy is borne by people in young age. To reduce the economic burden of epilepsy, effective prevention and treatment strategies are needed.

Summary

Citations

Citations to this article as recorded by  
  • Economic assessment of convulsive status epilepticus: Investigating socioeconomic correlations in hospitalization costs and outcomes in Northern India
    Ahmad Ghayas Ansari, Ariba Nasar, Hiba Nasar
    IP Indian Journal of Neurosciences.2024; 10(2): 78.     CrossRef
  • Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South Korea
    Ji Woong Lee, Jung-Ae Kim, Min Young Kim, Sang Kun Lee
    Epilepsy & Behavior.2022; 126: 108459.     CrossRef
  • Cost of Illness of Epilepsy and Associated Factors in Patients Attending Adult Outpatient Department of University of Gondar Referral Hospital, Northwest Ethiopia
    Piniel Melkamu, Yaregal Animut, Amare Minyihun, Asmamaw Atnafu, Mezgebu Yitayal
    Risk Management and Healthcare Policy.2021; Volume 14: 2385.     CrossRef
  • Cost–benefit analysis, cost-effectiveness analysis, and impact of antiepileptic drugs on the risk of fracture in patients with epilepsy: A nationwide cohort study
    Hsin-Hsuan Cheng, Pei-Tseng Kung, Bo-Ren Wang, Li-Ting Chiu, Wen-Chen Tsai
    Epilepsy & Behavior.2020; 103: 106851.     CrossRef
  • Introducing big data analysis using data from National Health Insurance Service
    EunJin Ahn
    Korean Journal of Anesthesiology.2020; 73(3): 205.     CrossRef
  • Epilepsy in Asia: Disease burden, management barriers, and challenges
    Eugen Trinka, Patrick Kwan, ByungIn Lee, Amitabh Dash
    Epilepsia.2019; 60(S1): 7.     CrossRef
  • The Present and Future of Vagus Nerve Stimulation
    Jeyul Yang, Ji Hoon Phi
    Journal of Korean Neurosurgical Society.2019; 62(3): 344.     CrossRef
  • Costs of informal nursing care for patients with neurologic disorders
    Freya Diederich, Hans-Helmut König, Claudia Mietzner, Christian Brettschneider
    Neurology.2018; 90(1): 28.     CrossRef
  • The Economic Burden of Hepatitis A, B, and C in South Korea
    Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh
    Japanese Journal of Infectious Diseases.2016; 69(1): 18.     CrossRef
  • A nationwide epidemiological study of newly diagnosed spine metastasis in the adult Korean population
    Seil Sohn, Jinhee Kim, Chun Kee Chung, Na Rae Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
    The Spine Journal.2016; 16(8): 937.     CrossRef
  • The direct costs of epilepsy in Russia. A prospective cost-of-illness study from a single center in Moscow
    Alla Guekht, Maria Mizinova, Igor Kaimovsky, Oksana Danilenko, Elisa Bianchi, Ettore Beghi
    Epilepsy & Behavior.2016; 64: 122.     CrossRef
A Strategy Toward Reconstructing the Healthcare System of a Unified Korea
Yo Han Lee, Seok-Jun Yoon, Seok Hyang Kim, Hyun-Woung Shin, Jin Yong Lee, Beomsoo Kim, Young Ae Kim, Jangho Yoon, Young Seok Shin
J Prev Med Public Health. 2013;46(3):134-138.   Published online May 31, 2013
DOI: https://doi.org/10.3961/jpmph.2013.46.3.134
  • 8,153 View
  • 109 Download
  • 3 Crossref
AbstractAbstract PDF

This road map aims to establish a stable and integrated healthcare system for the Korean Peninsula by improving health conditions and building a foundation for healthcare in North Korea through a series of effective healthcare programs. With a basic time frame extending from the present in stages towards unification, the roadmap is composed of four successive phases. The first and second phases, each expected to last five years, respectively, focus on disease treatment and nutritional treatment. These phases would thereby safeguard the health of the most vulnerable populations in North Korea, while fulfilling the basic health needs of other groups by modernizing existing medical facilities. Based on the gains of the first two phases, the third phase, for ten years, would prepare for unification of the Koreas by promoting the health of all the North Korean people and improving basic infrastructural elements such as health workforce capacity and medical institutions. The fourth phase, assuming that unification will take place, provides fundamental principles and directions for establishing an integrated healthcare system across the Korean Peninsula. We are hoping to increase the consistency of the program and overcome several existing concerns of the current program with this roadmap.

Summary

Citations

Citations to this article as recorded by  
  • Non-Communicable Diseases and Transitioning Health System in the Democratic People’s Republic of Korea during COVID-19 Lockdown
    Jin-Won Noh, Kyoung-Beom Kim, Ha-Eun Jang, Min-Hee Heo, Young-Jin Kim, Jiho Cha
    Healthcare.2022; 10(10): 2095.     CrossRef
  • Systematic review of evidence on public health in the Democratic People’s Republic of Korea
    John J Park, Ah-Young Lim, Hyung-Soon Ahn, Andrew I Kim, Soyoung Choi, David HW Oh, Owen Lee-Park, Sharon Y Kim, Sun Jae Jung, Jesse B Bump, Rifat Atun, Hee Young Shin, Kee B Park
    BMJ Global Health.2019; 4(2): e001133.     CrossRef
  • Awareness of Korean Unification and Health Care in Healthcare Professional Students
    Kyung Jin Jang, Yoon Ki Seoung, Su Hyun Yoon, Hye Seung Chumg, Soo Hyang Kim, You Lee Yang, Sang Hui Chu
    Journal of Korean Public Health Nursing.2016; 30(3): 456.     CrossRef
Overview of the Burden of Diseases in North Korea
Yo Han Lee, Seok-Jun Yoon, Young Ae Kim, Ji Won Yeom, In-Hwan Oh
J Prev Med Public Health. 2013;46(3):111-117.   Published online May 31, 2013
DOI: https://doi.org/10.3961/jpmph.2013.46.3.111
  • 22,027 View
  • 163 Download
  • 20 Crossref
AbstractAbstract PDF

This article evaluates the overall current disease burden of North Korea through the recent databases of international organizations. It is notable that North Korea as a nation is exhibiting a relatively low burden from deaths and that there is greater burden from deaths caused by non-communicable diseases than from those caused by communicable diseases and malnutrition. However, the absolute magnitude of problems from communicable diseases like TB and from child malnutrition, which will increase the disease burden in the future, remains great. North Korea, which needs to handle both communicable and nutritional conditions, and non-communicable diseases, whose burden is ever more increasing in the nation, can now be understood as a country with the 'double-burden' of disease.

Summary

Citations

Citations to this article as recorded by  
  • Understanding pediatric surgical needs in North Korea: a modeling analysis
    Phillip J Hsu, Sangchul Yoon, Kee B Park
    World Journal of Pediatric Surgery.2024; 7(1): e000697.     CrossRef
  • The Possible Impact of Nationwide Vaccination on Outcomes of the COVID-19 Epidemic in North Korea: A Modelling Study
    Sung-mok Jung, Jaehun Jung
    Journal of Korean Medical Science.2022;[Epub]     CrossRef
  • Trends and patterns of North Korea’s disease burden from 1990 to 2019: Results from Global Burden of Disease study 2019
    Eun Hae Lee, Minjae Choi, Joshua Kirabo Sempungu, Yo Han Lee, Negar Rezaei
    PLOS ONE.2022; 17(11): e0277335.     CrossRef
  • Non-Communicable Diseases and Transitioning Health System in the Democratic People’s Republic of Korea during COVID-19 Lockdown
    Jin-Won Noh, Kyoung-Beom Kim, Ha-Eun Jang, Min-Hee Heo, Young-Jin Kim, Jiho Cha
    Healthcare.2022; 10(10): 2095.     CrossRef
  • Prediction of cardiovascular diseases mortality- and disability-adjusted life-years attributed to modifiable dietary risk factors from 1990 to 2030 among East Asian countries and the world
    Nawsherwan, Wang Bin, Zhang Le, Sumaira Mubarik, Guo Fu, Yan Wang
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Trend of Disease Burden of North Korean Defectors in South Korea Using Disability-adjusted Life Years from 2010 to 2018
    Keun A Kim, Yoon-Sun Jung, Chae-Bong Kim, Ki-Beom Kim, Seok-Jun Yoon
    Journal of Korean Medical Science.2021;[Epub]     CrossRef
  • Global estimated Disability-Adjusted Life-Years (DALYs) of diarrheal diseases: A systematic analysis of data from 28 years of the global burden of disease study
    Natacha U. Karambizi, Christopher S. McMahan, Carl N. Blue, Lesly A. Temesvari, Srinivas Goli
    PLOS ONE.2021; 16(10): e0259077.     CrossRef
  • Surgical Diseases in North Korea: An Overview of North Korean Medical Journals
    Sejin Choi, Taehoon Kim, Soyoung Choi, Hee Young Shin
    International Journal of Environmental Research and Public Health.2020; 17(24): 9346.     CrossRef
  • Perceptions of the Osteopathic Profession in New York City's Korean Communities
    Justin Chin, DO, Haeinn Woo, OMS-IV, Diane Choi, OMS-III, Emily Dube, MS, Mikhail Volokitin, MD, DO, Christine Lomiguen, MD
    Osteopathic Family Physician.2020; 13(1): 12.     CrossRef
  • Epidemiology survey of infectious diseases in North Korean travelers, 2015–2017
    Pengyu Han, Yanxia Teng, Xiuxin Bi, Jinge Li, Dianxing Sun
    BMC Infectious Diseases.2019;[Epub]     CrossRef
  • Underestimated Burden: Non-Communicable Diseases in North Korea
    Shin Ha, Yo Han Lee
    Yonsei Medical Journal.2019; 60(5): 481.     CrossRef
  • Frequently covered diseases in North Korean internal medicine journal Internal Medicine [Naegwa]—Secondary publication
    Shin Ha, Yo Han Lee
    Science Editing.2019; 6(2): 99.     CrossRef
  • Infectious disease risks among refugees from North Korea
    Hiroshi Nishiura, Hyojung Lee, Baoyin Yuan, Akira Endo, Andrei R. Akhmetzhanov, Gerardo Chowell
    International Journal of Infectious Diseases.2018; 66: 22.     CrossRef
  • The life expectancy gap between North and South Korea from 1993 to 2008
    Jinwook Bahk, Majid Ezzati, Young-Ho Khang
    European Journal of Public Health.2018; 28(5): 830.     CrossRef
  • The Status and Distinct Characteristics of Endocrine Diseases in North Korean Articles Published between 2006 and 2015
    Kyeong Jin Kim, Shin Ha, Yo Han Lee, Jung Hyun Noh, Sin Gon Kim
    Endocrinology and Metabolism.2018; 33(2): 268.     CrossRef
  • A Program to Treat Hepatitis B in North Korea: A Model of Antiviral Therapy in a Resource-Poor Setting
    Alice Unah Lee, Heidi Linton, Marcia Kilsby, David C. Hilmers
    Gut and Liver.2018; 12(6): 615.     CrossRef
  • Fighting Hepatitis B in North Korea: Feasibility of a Bi-modal Prevention Strategy
    Markus Unnewehr, August Stich
    Journal of Korean Medical Science.2015; 30(11): 1584.     CrossRef
  • The social and political construction of health-care systems – historical observations from selected countries in Asia
    John Grundy, Elizabeth Hoban, Steve Allender
    Health Systems.2015; 4(2): 124.     CrossRef
  • Public Health and International Partnerships in the Democratic People’s Republic of Korea
    John Grundy, Beverley-Ann Biggs, David B. Hipgrave
    PLOS Medicine.2015; 12(12): e1001929.     CrossRef
  • North Korea: a challenge for global solidarity
    Espen Bjertness, Ahmed Ali Madar
    The Lancet.2014; 383(9926): 1381.     CrossRef
Impact of Changes in Maternal Age and Parity Distribution on Low Birth Weight Incidence Rate.
Young Ae Kim, Jung Han Park
Korean J Prev Med. 1989;22(2):276-282.
  • 1,997 View
  • 19 Download
AbstractAbstract PDF
The objective of this study was to examine the impact of changes in maternal age and parity distribution on birth weight. The study population included 7,786 single live births in 1987 delivered at 9 medical facilities in Pusan. Data were obtained from the delivery record. The proportion of infants born to the mothers of 25-29 years increased from 56.4% in 1977 to 65.1% in 1987 and the proportion to the mothers of 30-34 years increased from 18.8% in 1977 to 21.6% in 1987. In the same period, the proportions of 1st and 2nd birth order were increased from 56.9% and 28.8% to 59.9% and 36.8%, respectively. The proportion of infants born to the age group of < or = 24 and 35 < or = years were decreased in 1987. The proportion of births of the third or higher birth order was decreased from 14.2% in 1977 to 3.3% in 1987. Low birth weight (<2500gm) incidence rate was 5.3% in 1977 and it was decreased to 4.0% in 1987. It was estimated that changes in maternal age-parity distribution accounted for 10.7% of the decreased in low birth weight incidence rate. Rest of the change (89.3%) was attributed to the reduction of age-parity specific low birth weight incidence rate. Application of the direct adjustment method was considered to be an adequate tool for evaluating the impact of family planning on neonatal health.
Summary

JPMPH : Journal of Preventive Medicine and Public Health